NASDAQ : OMCL
Omnicell, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 36.65 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.67B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.67B |
| Enterprise Value | 1.55B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 45.61M |
| Shares Outstanding | 45.61M |
| Shares Change (YoY) | -1.53% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 2.67% |
| Owned by Institutions (%) | 109.29% |
| Float | 44.38M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 38.04 |
| Forward PE | 19.02 |
| PS Ratio | 1.34 |
| Forward PS | 1.36 |
| PB Ratio | 1.28 |
| P/TBV Ratio | 3.95 |
| P/FCF Ratio | 11.66 |
| P/OCF Ratio | 8.98 |
| PEG Ratio | 0.74 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 34.63 |
| EV / Sales | 1.24 |
| EV / EBITDA | 15.07 |
| EV / EBIT | 21.51 |
| EV / FCF | 10.79 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.66 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 1.69 |
| Debt / FCF | 1.32 |
| Interest Coverage | 15.34 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 3.52% |
| Return on Assets (ROA) | 2.24% |
| Return on Invested Capital (ROIC) | 3.99% |
| Return on Capital Employed (ROCE) | 4.54% |
| Weighted Average Cost of Capital (WACC) | 8.85% |
| Revenue Per Employee | $356,936 |
| Profits Per Employee | $12,816 |
| Employee Count | 3,485 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 6.58 |
Taxes
| Measure | Value |
|---|
| Income Tax | 22.58M |
| Effective Tax Rate | 33.57% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +23.94% |
| 50-Day Moving Average | 34.60 |
| 200-Day Moving Average | 39.03 |
| Relative Strength Index (RSI) | 55.48 |
| Average Volume (20 Days) | 533,959 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.27M |
| Short Previous Month | 3.64M |
| Short % of Shares Out | 7.16% |
| Short % of Float | 7.36% |
| Short Ratio (days to cover) | 6.58 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.24B |
| Gross Profit | 566.79M |
| Operating Income | 71.89M |
| Pretax Income | 67.24M |
| Net Income | 44.67M |
| EBITDA | 102.62M |
| EBIT | 71.89M |
| Earnings Per Share (EPS) | $0.96 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 314.86M |
| Total Debt | 189.67M |
| Net Cash | 125.19M |
| Net Cash Per Share | $2.74 |
| Equity (Book Value) | 1.32B |
| Book Value Per Share | 28.70 |
| Working Capital | 310.28M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 186.22M |
| Capital Expenditures | -42.88M |
| Depreciation & Amortization | 30.72M |
| Net Borrowing | n/a |
| Free Cash Flow | 143.34M |
| FCF Per Share | $3.14 |
Margins
| Measure | Value |
|---|
| Gross Margin | 45.56% |
| Operating Margin | 5.78% |
| Pretax Margin | 5.41% |
| Profit Margin | 3.59% |
| EBITDA Margin | 8.25% |
| EBIT Margin | 5.78% |
| FCF Margin | 11.52% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.53% |
| Shareholder Yield | 1.53% |
| Earnings Yield | 2.63% |
| FCF Yield | 8.57% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $57.71 |
| Price Target Difference | 57.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 3.28% |
| EPS Growth Forecast (3Y) | 13.36% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |